logo

SRPT

Sarepta·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

SRPT fundamentals

Sarepta (SRPT) released its earnings on Nov 3, 2025: revenue was 399.40M (YoY -14.51%), beat estimates; EPS was -0.13 (YoY -120.97%), beat estimates.
Revenue / YoY
399.40M
-14.51%
EPS / YoY
-0.13
-120.97%
Report date
Nov 3, 2025
SRPT Earnings Call Summary for Q3,2025
  • ESSENCE Trial Update: 30% disease progression reduction in COVID-free patients, with real-world data showing 3-year delay in loss of ambulation.
  • FDA Confidence: Likely acceptance of 0.09 p-value, with totality of evidence supporting continued PMO authorization.
  • Financial Resilience: Q3 revenue $399M, $865M cash, and $500M ELEVIDYS floor for ambulatory patients.
  • Pipeline Momentum: siRNA trials advancing, with DM1 and FSHD data expected Q1 2026.
EPS
Revenue

Revenue & Expenses

SRPT has released its 2025 Q3 earnings report, with revenue of 399.36M, reflecting a YoY change of -14.52%, and net profit of -179.95M, showing a YoY change of -635.38%. The Sankey diagram below clearly presents SRPT's revenue sources and cost distribution.

Key Indicators

Sarepta (SRPT) key financial stats and ratios, covering profitability, financial health, and leverage.
Sarepta (SRPT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Sarepta (SRPT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Sarepta (SRPT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Sarepta (SRPT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Sarepta (SRPT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield